Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125369641 | 12536964 | 1 | I | 20160327 | 20160422 | 20160707 | 20160707 | EXP | JP-ELI_LILLY_AND_COMPANY-JP201604009830 | ELI LILLY AND CO | 83.00 | YR | M | Y | 55.50000 | KG | 20160707 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125369641 | 12536964 | 1 | PS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 20 MG, QD | Y | 21427 | 20 | MG | CAPSULE | QD | |||||
| 125369641 | 12536964 | 2 | C | LOXONIN | LOXOPROFEN SODIUM | 1 | 0 | ||||||||||||
| 125369641 | 12536964 | 3 | C | MOHRUS | KETOPROFEN | 1 | Transdermal | UNK | 0 | ||||||||||
| 125369641 | 12536964 | 4 | C | SG /01737201/ | 2 | Oral | 0 | GRANULES |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125369641 | 12536964 | 1 | Back pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125369641 | 12536964 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125369641 | 12536964 | Hypoaesthesia | |
| 125369641 | 12536964 | Nausea | |
| 125369641 | 12536964 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125369641 | 12536964 | 1 | 20160324 | 20160327 | 0 |